Sit Investment Associates’s Novartis NVS Stock Holding History

Sit Investment Associates’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,450	Closed	-$430K	–	541
2024 Q1	$430K	Hold	4,450	–	–	0.01%	417
2023 Q4	$449K	Hold	4,450	–	–	0.01%	420
2023 Q3	$453K	Hold	4,450	–	–	0.01%	406
2023 Q2	$449K	Sell	4,450 -2,415	-35%	-$242K	0.01%	427
2023 Q1	$632K	Sell	6,865 -3,935	-36%	-$344K	0.02%	388
2022 Q4	$980K	Hold	10,800	–	–	0.03%	352
2022 Q3	$821K	Hold	10,800	–	–	0.02%	350
2022 Q2	$913K	Hold	10,800	–	–	0.03%	336
2022 Q1	$948K	Hold	10,800	–	–	0.03%	356
2021 Q4	$945K	Sell	10,800 -6,700	-38%	-$556K	0.02%	373
2021 Q3	$1.43M	Hold	17,500	–	–	0.04%	326
2021 Q2	$1.6M	Hold	17,500	–	–	0.04%	325
2021 Q1	$1.5M	Hold	17,500	–	–	0.04%	326
2020 Q4	$1.65M	Hold	17,500	–	–	0.04%	313
2020 Q3	$1.52M	Hold	17,500	–	–	0.04%	309
2020 Q2	$1.53M	Hold	17,500	–	–	0.05%	293
2020 Q1	$1.44M	Hold	17,500	–	–	0.05%	294
2019 Q4	$1.66M	Hold	17,500	–	–	0.05%	310
2019 Q3	$1.52M	Buy	17,500 +1,800	+11%	+$162K	0.05%	303
2019 Q2	$1.43M	Sell	15,700 -1,821	-10%	-$154K	0.04%	311
2019 Q1	$1.51M	Hold	17,521	–	–	0.05%	291
2018 Q4	$1.35M	Hold	17,521	–	–	0.04%	302
2018 Q3	$1.35M	Hold	17,521	–	–	0.03%	298
2018 Q2	$1.19M	Sell	17,521 -3,460	-16%	-$239K	0.03%	337
2018 Q1	$1.52M	Sell	20,981 -217	-1%	-$16.5K	0.04%	319
2017 Q4	$1.59M	Hold	21,198	–	–	0.04%	321
2017 Q3	$1.63M	Hold	21,198	–	–	0.04%	308
2017 Q2	$1.59M	Buy	21,198 +664	+3%	+$47.1K	0.04%	305
2017 Q1	$1.37M	Buy	+20,534	New	+$1.37M	0.03%	325

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CCM

Cullen Capital Management New York $9.75B AUM 21.81% 1-Year Est. Return

Sit Investment Associates's NVS Position: Q2 2024 in Review

Sit Investment Associates sold out of Novartis (NVS) in Q2 2024, closing a stake of 4,450 shares — an estimated $430K sold.

Sit Investment Associates first reported a position in NVS in Q1 2017 and held it in 29 quarters. The position peaked at $1.66M in Q4 2019. 1,306 funds tracked by Wall St. Rank hold NVS as of Q2 2024.

Sit Investment Associates reported no remaining Novartis position as of Q2 2024 after selling out during the quarter.
Sit Investment Associates sold 4,450 Novartis shares in Q2 2024, an estimated $430K.
Sit Investment Associates first reported a position in Novartis in Q1 2017 and held it in 29 quarters.
Sit Investment Associates's Novartis position peaked at $1.66M in Q4 2019.
1,306 funds tracked by Wall St. Rank held Novartis as of Q2 2024.

Based on Sit Investment Associates's 13F filing for Q2 2024, filed 14 Aug 2024.